C07H 21/02
Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate
Official title: with ribosyl as saccharide radical
C07H21/02 (Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate) appears on 1,318 US grants and 2,203 published applications in this corpus.
Search patents in C07H- Granted patents
- 1,318
- Published applications
- 2,203
- Assignees
- 736
- Inventors
- 3,328
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 8 | 0 |
| 1998 | 3 | 0 |
| 1999 | 9 | 0 |
| 2000 | 3 | 0 |
| 2001 | 9 | 1 |
| 2002 | 7 | 9 |
| 2003 | 10 | 31 |
| 2004 | 18 | 67 |
| 2005 | 20 | 109 |
| 2006 | 17 | 74 |
| 2007 | 17 | 88 |
| 2008 | 41 | 66 |
| 2009 | 33 | 94 |
| 2010 | 54 | 63 |
| 2011 | 50 | 64 |
| 2012 | 53 | 67 |
| 2013 | 43 | 115 |
| 2014 | 69 | 93 |
| 2015 | 79 | 88 |
| 2016 | 75 | 99 |
| 2017 | 54 | 87 |
| 2018 | 59 | 106 |
| 2019 | 83 | 125 |
| 2020 | 85 | 120 |
| 2021 | 90 | 101 |
| 2022 | 61 | 119 |
| 2023 | 71 | 120 |
| 2024 | 72 | 94 |
| 2025 | 69 | 134 |
| 2026 | 45 | 69 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition for use in treating dystrophic epidermolysis bullosa6 Oct 2026US 12,751,974 B2Osaka University
- Synthesis of oligomeric compounds comprising phosphorothioate diester and phosphodiester linkages29 Sep 2026US 12,747,260 B2Ionis Pharmaceuticals, Inc.
- MRNA 5′-end cap analogs modified within phosphate residues, RNA molecule incorporating the same, uses thereof and method of synthesizing RNA molecule or peptide29 Sep 2026US 12,747,261 B2Explorna Therapeutics Sp. z o.o.
- Methods for RNA analysis8 Sep 2026US 12,729,395 B2CureVac Manufacturing GmbH
- Chiral synthons for the synthesis of chiral phosphorothioates25 Aug 2026US 12,715,885 B2Boehringer Ingelheim International GmbH
- Synthesis of cap-2 mrna8 Oct 2026US 2026/0308652 A1Arizona Board of Regents on behalf of Arizona State University
- Splice switcher antisense oligonucleotides with modified backbone chemistries17 Sep 2026US 2026/0275333 A1Quralis Corporation
- Compounds and methods for modulating angiotensinogen expression10 Sep 2026US 2026/0263503 A1Ionis Pharmaceuticals, Inc.
- Complement factor b-modulating compositions and methods of use thereof3 Sep 2026US 2026/0258422 A1ADARx Pharmaceuticals, Inc.
- Mrna cap analog and method for producing same, method for producing mrna, and kit27 Aug 2026US 2026/0250311 A1Yamasa Corporation
Most cited
By later US patents
- Manipulation of microparticles in microfluidic systems765US 6,632,655 B1Caliper Technologies Corp. · 2003
- DNA sequencing by parallel oligonucleotide extensions674US 5,750,341 ALynx Therapeutics, Inc. · 1998
- DNA sequencing by parallel oligonucleotide extensions649US 6,306,597 B1Lynx Therapeutics, Inc. · 2001
- Backbone modified oligonucleotide analogues637US 5,610,289 AIsis Pharmaceuticals, Inc. · 1997
- Polynucleotide phosphorodithioate595US 5,453,496 AUniversity Patents, Inc. · 1995